Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dissected Brains of Fruit Flies Provide Clues in Autism Research

Published: Thursday, January 29, 2009
Last Updated: Monday, February 02, 2009
Bookmark and Share
A new bioassay methodology identifies drugs that may increase the cognitive functionality of children with mental retardation or autism.

Dr. Linda Restifo in Arizona Research Laboratory's (ARL) Division of Neurobiology has developed a promising methodology that uses fruit fly brains to screen for drugs that may increase the cognitive functionality of children with mental retardation or autism. The fruit fly brain has similar proteins and developmental mechanisms to those in human brains.

Restifo is testing drugs that are already approved by the FDA to determine whether and how well those drugs can change the size or shape of genetically abnormal brain neurons.

In a recently completed experiment, Restifo and her research team found several dozen drugs that straighten out curly brain neurons. The curliness results from lack of a protein that is thought to be important to brain development. The resounding success of the proof-of-concept study suggests a novel strategy for finding safe and effective drug treatments for mental retardation and autism in people.

Restifo is the first to use primary neuron culture for drug screening of this type. To conduct her research, Restifo and members of her lab monitor the size and shape of individual brain cells that have been dissected from the brain of a developing fruit fly at the maggot stage and allowed to grow in a laboratory culture dish. Each group of cells is treated with a single drug. The drugs selected for use by Restifo come from a collection of ~ 1,000 known drugs, most of which are already approved by FDA for other disease uses. In the neuron bioassay, cells are grown for three days and then observed under the microscope for changes the drug has caused in the size or shape of the neurons.

“Nobody is using a brain neuron assay in this way for drug screening.” commented Restifo. “The small size and short life cycle of fruit flies is advantageous at this stage. Over the next several years, we hope to move the experiments to mice and rats and eventually to human trials. It’s gratifying to think our research may identify drugs that help combat the behavioral and cognitive symptoms that affect children with mental retardation and autism. The therapeutic strategy does not promise a cure for autism, but rather the hope is to increase an individual’s functionality.”

“ARL is proud to support Dr. Restifo’s groundbreaking research,” said Michael Cusanovich, ARL Director. “Most assays don’t have a drug development slant and this has enormous potential as a demonstration project. Over the long-term, the fact the drugs in this study are being repurposed and are already FDA approved could make this effort an attractive investment opportunity. Dr. Restifo's medical background coupled with research focus in fruit fly genetics have enabled her to design a tremendously important methodology that may lead to therapeutic treatments for numerous neurological conditions, including autism.”

At the same time Restifo’s research has revealed FDA approved drugs that straighten out neuron curls, she has discovered that certain other drugs increase neuron curliness. Restifo is also currently conducting research to determine if drugs that increase neuron curliness would serve as treatments against certain invasive cancers, such as malignant glioma, the most deadly type of brain cancer. She is using the same neuron-culture methodology for the cancer and the autism projects, in both cases seeking therapeutic agents that change the shape of neurons from the fruit fly brain.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Thursday, February 11, 2016
Worldwide Resource for Exploring Genes' Hidden Messages
After a decade-long $3 billion international effort, scientists heralded the 2001 completion of the human genome as a moon landing achievement for biology and the key to finally solving intractable diseases like cancer.
Tuesday, December 15, 2015
Carbon Nanotubes Show Promise for High-Speed Genetic Sequencing
Faster sequencing of DNA holds potential for personalized diagnosis and customized treatment based on each individual's genomic makeup.
Monday, January 04, 2010
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Unexpected Epigenetic Enzymes Role in Cancer
Researchers use epigenetics to identify the role of an enzyme family as regulators of genetic message interpretation in yeast.
Genetic Links to Brain Cancer Cell Growth
Researchers discover clues to tumour behaviour from genetic differences between brain cancer cells and normal tissue cells.
New Form of Autism Found
An international team of researchers have identified a new form of syndromic autism.
Tissue Damage Is Key for Cell Reprogramming
Researchers have shown tissue damage is important for cells to return to an embryonic state for cell reprogramming.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!